Evidence map›Paper›PMID 29861819›Full record

ArticleBiomicrofluidics2018

Microfluidic flow-based platforms for induction and analysis of dynamic shear-mediated platelet activation-Initial validation versus the standardized hemodynamic shearing device.

Annalisa Dimasi, Yana Roka-Moiia, Filippo Consolo, Marco Rasponi, Gianfranco B Fiore, Marvin J Slepian, Alberto Redaelli

Open access · bronzeAbstract read
In one paragraph

Article in Biomicrofluidics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Annalisa DimasiDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Via Golgi 39, 20133 Milano, Italy.
Yana Roka-MoiiaDepartment of Medicine and Biomedical Engineering, Sarver Heart Center, University of Arizona, 1501 N Campbell Ave, Tucson, Arizona 85724, USA.ORCID 0000-0001-7709-1666
Marco RasponiDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Via Golgi 39, 20133 Milano, Italy.ORCID 0000-0002-2904-8652
Gianfranco B FioreDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Via Golgi 39, 20133 Milano, Italy.
Marvin J SlepianDepartment of Medicine and Biomedical Engineering, Sarver Heart Center, University of Arizona, 1501 N Campbell Ave, Tucson, Arizona 85724, USA.ORCID 0000-0002-7864-6691
Alberto RedaelliDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Via Golgi 39, 20133 Milano, Italy.ORCID 0000-0002-9020-2188
Politecnico di Milano · ITUniversity of Arizona · USVita-Salute San Raffaele University · IT

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
NCI NIH HHS P30 CA023074
6 · The paper itself

Abstract

A microfluidic flow-based platform (μFP), able to stimulate platelets via exposure of shear stress patterns pertinent to cardiovascular devices and prostheses, was compared to the Hemodynamic Shearing Device (HSD)-a state-of-the-art bench-top system for exposure of platelets to defined levels and patterns of shear. Platelets were exposed to time-varying shear stress patterns in the two systems; in detail, platelets were recirculated in the μFP or stimulated in the HSD to replicate comparable exposure time. Shear-mediated platelet activation was evaluated via (i) the platelet activity state assay, allowing the measurement of platelet-mediated thrombin generation and associated prothrombotic tendencies, (ii) scanning electron microscopy to evaluate morphological changes of sheared platelets, and (iii) flow cytometry for the determination of platelet phosphatidylserine exposure as a marker of shear activation. The results revealed good matching and comparability between the two systems, with similar trends of platelet activation, formation of microaggregates, and analogous trends of activation marker exposure for both the HSD and microfluidic-stimulated samples. These findings support future translation of the microfluidic platform as a Point-of-Care facsimile system for the diagnosis of thrombotic risk in patients implanted with cardiovascular devices.

Identifiers

PMID29861819
PMCPMC5963949
OpenAlexW2803578821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.